Evidence map›Paper›PMID 35341565›Full record

ArticleAdvances in pharmacology (San Diego, Calif.)2022

Stimulus functions of nicotine.

Mark G LeSage

Open access · greenAbstract read
In one paragraph

Article in Advances in pharmacology (San Diego, Calif.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Mark G LeSageHennepin Healthcare Research Institute, Minneapolis, MN, United States; Departments of Medicine, Pharmacology, and Psychology, University of Minnesota, Minneapolis, MN, United States. Electronic address: lesag002@umn.edu.
Hennepin Healthcare Research Institute · US

Funding

Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco productsR01DA048899 · NIDA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI HARRIS, ANDREW CHARLES, LESAGE, MARK G · 2020 to 2024
$3.4M
Animal models to inform FDA tobacco regulation: Assessing the relative abuse liability of different classes of tobacco productsR01DA046318 · NIDA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI HARRIS, ANDREW CHARLES, LESAGE, MARK G · 2018 to 2020
$1.3M
NIDA NIH HHS R01 DA046318NIDA NIH HHS R01 DA048899
6 · The paper itself

Abstract

Behavioral pharmacology has made vital contributions to the concepts and methods used in tobacco and other drug use research, and is largely responsible for the now generally accepted notion that nicotine is the primary component in tobacco that engenders and maintains tobacco use. One of the most important contributions of behavioral pharmacology to the science of drug use is the notion that drugs can act as environmental stimuli that control behavior in many of the same ways as other stimuli (e.g., visual, gustatory, olfactory). The purpose of this chapter is to provide an overview of research that illustrates the respondent and operant stimulus functions of nicotine, using a contemporary taxonomy of stimulus functions as a general framework. Each function is formally defined and examples from research on the behavioral pharmacology of nicotine are presented. Some of the factors that modulate each function are also discussed. The role of nicotine's stimulus functions in operant and respondent theories of tobacco use is examined and some suggestions for future research are presented. The chapter illustrates how a taxonomy of stimulus functions can guide conceptions of tobacco use and direct research and theory accordingly.

Indexed as

NicotineHumansNicotineBehavioral pharmacologyBehavior analysisNicotineOperant conditioningRespondent conditioningStimulus functions

Identifiers

PMID35341565
PMCPMC9438898
OpenAlexW4206024704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.